Long and Short-term Metformin Consumption as a Potential Therapy to Prevent Complications of COVID-19

Elnaz Shaseb ^1,2 , Saba Ghaffary ^2,3 * , Alireza Garjani ², Elnaz Zoghi ⁴, Nasrin Maleki Dizaji ², Somaieh Soltani ², Parvin Sarbakhsh ⁵, Mohammad Hossein Somi ⁶, Parya Valizadeh ⁷, Ali Taghizadieh ⁸, Masood Faghihdinevari ⁶, Mojtaba Varshochi ⁹, Behrooz Naghily ⁹, Zhinous Bayatmakoo ⁹, Parviz Saleh ⁹, Sepehr Taghizadeh ⁹, Mehdi Haghdoost ⁹, Hamid Owaysi ⁹, Fatemeh Ravanbakhsh Ghavghani ⁹, Mohammad Kazem Tarzamni ¹⁰, Rojin Moradi ¹⁰, Fateme Javan Ali Azar ¹¹, Saeid Shabestari Khiabani ¹, Ardavan Ghazanchaei ¹², Sana Hamedani ², Shahabeddin Hatefi ²

Cited by CrossRef: 3

1- Valencia I, Lumpuy-Castillo J, Magalhaes G, Sánchez-Ferrer C, Lorenzo Ó, Peiró C. Mechanisms of endothelial activation, hypercoagulation and thrombosis in COVID-19: a link with diabetes mellitus. Cardiovasc Diabetol. 2024;23(1) [Crossref]

2- Huang Q, Ren Y, Yuan P, Huang M, Liu G, Shi Y, Jia G, Chen M. Targeting the AMPK/Nrf2 Pathway: A Novel Therapeutic Approach for Acute Lung Injury. JIR. 2024;Volume 17:4683 [Crossref]

3- Kow C, Ramachandram D, Hasan S. Unlocking the enigma: Metabolic risks of typical antipsychotics and their link to COVID-19 mortality. European Neuropsychopharmacology. 2024;78:1 [Crossref]